![Aaron Freidin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 7 M $ al 31/05/2026
Aaron Freidin is Chief Financial Officer at GRAIL, Inc. since 2021.
Formerly, Mr. Freidin was Vice President & Controller at Myriad Women's Health, Inc. from 2015 to 2016.
Mr. Freidin completed undergraduate studies at the University of California.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GRAIL INC 0,24 % | 22/04/2026 | 103.888 ( 0,24 % ) | 7 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GRAIL, INC. | Director Financiero/CFO | 01/11/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
Myriad Women's Health, Inc.
 Myriad Women's Health, Inc. Medical/Nursing ServicesHealth Services Provides pre-pregnancy genetic testing services | Comptroller/Controller/Auditor | 01/08/2016 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Myriad Women's Health, Inc.
Myriad Women's Health, Inc. Medical/Nursing ServicesHealth Services Provides pre-pregnancy genetic testing services | Health Services |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GRAIL, Inc.
 GRAIL, Inc. Medical SpecialtiesHealth Technology Manufactures cancer detection test kits and provides related services | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
